AusPAR: Spevigo

Australian Public Assessment Report

AusPAR

AusPAR: SPEVIGO [PDF, 2.09 MB]

AusPAR: SPEVIGO [Word, 4.82 MB]

Attachment Product information for SPEVIGO [PDF, 197.45 KB]

Attachment Product information for SPEVIGO [Word, 175.05 KB]

Device/Product Name

SPEVIGO

Active ingredients

Spesolimab

AusPAR Date

3 July 2024

Published

18 July 2024

Submission Number

PM-2022-01272-1-1

Submission Type

New biological entity

Decision

Approved